<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04979091</url>
  </required_header>
  <id_info>
    <org_study_id>HAM-SEX-C19</org_study_id>
    <nct_id>NCT04979091</nct_id>
  </id_info>
  <brief_title>Sex Hormone Dysregulations Are Associated With Critical Illness in COVID-19 Patients</brief_title>
  <acronym>HAM-SEX-C19</acronym>
  <official_title>Low Testosterone and High Estradiol Are Associated With Disease Severity in Critically Ill COVID-19 Patients - a Retrospective Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal Ministry of Health, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Males develop more severe SARS-CoV-2 infection related disease outcome than females. Herein,&#xD;
      sex hormones were repeatedly proposed to play an important role in Covid-19 pathophysiology&#xD;
      and immunity. However, it is yet unclear whether sex hormones are associated with Covid-19&#xD;
      outcome in males and females. In this study, we analyzed sex hormones, cytokine and chemokine&#xD;
      responses as well as performed a large profile analysis of 600 metabolites in critically-ill&#xD;
      male and female Covid-19 patients in comparison to healthy controls and patients with&#xD;
      coronary heart diseases as a prime Covid-19 comorbidity. We here show that dysregulated sex&#xD;
      hormones, IFN-γ levels and unique metabolic signatures are associated with critical illness&#xD;
      in Covid-19 patients. Both, male and female Covid-19 patients, present elevated estradiol&#xD;
      levels which positively correlates with IFN-γ levels.&#xD;
&#xD;
      Male Covid-19 patients additionally display severe testosterone and triglyceride deficiencies&#xD;
      as compared to female patients and healthy controls. Our results suggest that male Covid-19&#xD;
      patients suffer from multiple metabolic disorders, which may lead to higher risk for fatal&#xD;
      outcome. These findings will help to understand molecular pathways involved in Covid-19&#xD;
      pathophysiology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 8, 2020</start_date>
  <completion_date type="Actual">May 31, 2021</completion_date>
  <primary_completion_date type="Actual">February 26, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sex hormone in critical ill COVID-19 patients</measure>
    <time_frame>Day at admission</time_frame>
    <description>testosterone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sex hormone in critical ill COVID-19 patients</measure>
    <time_frame>Day at admission</time_frame>
    <description>estradiol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sex hormone in critical ill COVID-19 patients</measure>
    <time_frame>Day at admission</time_frame>
    <description>sex hormone-binding globulin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sex hormone in critical ill patients</measure>
    <time_frame>Day at admission</time_frame>
    <description>testosterone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sex hormone in critical ill patients</measure>
    <time_frame>Day at admission</time_frame>
    <description>estradiol</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Covid19</condition>
  <condition>Critical Illness</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Sex Hormones</intervention_name>
    <description>A panel of 13 hormones was measured in plasma samples of COVID-19 patients (total testosterone, free testosterone, dihydrotestosterone, androstenedione, 17-β-estradiol, estrone, sex hormone-binding globulin, thyroid-stimulating hormone, free triiodothyronine (T3), free thyroxine (T4), luteinizing hormone, follicle-stimulating hormone and cortisol).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill Covid-19 patients and Critically ill Non-Covid-19 patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admission on ICU&#xD;
&#xD;
          -  Covid-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Kluge, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Medical Center Hamburg-Eppendorf, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Medical Center</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://www.medrxiv.org/content/10.1101/2020.05.07.20073817v2</url>
    <description>Preprint</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 25, 2021</study_first_submitted>
  <study_first_submitted_qc>July 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>August 1, 2021</last_update_submitted>
  <last_update_submitted_qc>August 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICU, COVID-19, testosteron, estradiol, sex-hormone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

